Sign-up for Bloomin' Brands Announces 2014 Third Quarter Adjusted Diluted EPS of $0.10 and Diluted EPS of $(0.09); Reaffirms Adjusted Diluted EPS Guidance of Between $1.05 and $1.10; Posts Core Domestic Comparable Sales Increase of 3.3%; Details Restructuring Plan for South Korea investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has
launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent
generic version of RAPAMUNE ® (Sirolimus) tablets in the US
market on October 27, 2014, following the approval by the United States
Food & Drug Administration (USFDA).
The RAPAMUNE ® tablets brand had U.S. sales of approximately
$206 Million MAT for the most recent twelve months ending in August 2014
according to IMS Health*.
Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE:IBP),
an industry-leading installer of insulation and complementary building
products, announced today results for the third quarter ended September
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.